WELLS FARGO & COMPANY/MN - NEUBERGER BERMAN HGH YLD FD ownership

NEUBERGER BERMAN HGH YLD FD's ticker is NHS and the CUSIP is 64128C106. A total of 51 filers reported holding NEUBERGER BERMAN HGH YLD FD in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of NEUBERGER BERMAN HGH YLD FD
ValueSharesWeighting
Q3 2023$146,164
-7.2%
19,411
-7.7%
0.00%
Q2 2023$157,562
+43.4%
21,036
+63.1%
0.00%
Q1 2023$109,883
+3.4%
12,896
+3.4%
0.00%
Q4 2022$106,253
-4.3%
12,471
-11.3%
0.00%
Q3 2022$111,000
-4.3%
14,065
+1.2%
0.00%
Q2 2022$116,000
-26.1%
13,897
+0.8%
0.00%
Q1 2022$157,000
-9.2%
13,781
-1.1%
0.00%
Q4 2021$173,000
-16.4%
13,940
-15.0%
0.00%
Q3 2021$207,000
-5.0%
16,397
-0.1%
0.00%
Q2 2021$218,000
-13.5%
16,421
-16.1%
0.00%
Q1 2021$252,000
-28.0%
19,568
-34.6%
0.00%
Q4 2020$350,000
-63.5%
29,913
-65.4%
0.00%
Q3 2020$960,000
-33.9%
86,537
-38.3%
0.00%
Q2 2020$1,453,000
+12.1%
140,353
-6.0%
0.00%
Q1 2020$1,296,000
-37.1%
149,282
-10.5%
0.00%
-100.0%
Q4 2019$2,059,000
+4.5%
166,732
+2.1%
0.00%0.0%
Q3 2019$1,970,000
-8.6%
163,237
-11.4%
0.00%0.0%
Q2 2019$2,155,000
-72.6%
184,175
-73.6%
0.00%
-50.0%
Q1 2019$7,870,000
-42.2%
697,050
-50.5%
0.00%
-60.0%
Q4 2018$13,615,000
-0.2%
1,407,948
+13.0%
0.01%
+25.0%
Q3 2018$13,642,000
+23.7%
1,245,773
+22.2%
0.00%
+33.3%
Q2 2018$11,026,000
+12.8%
1,019,072
+16.1%
0.00%0.0%
Q1 2018$9,778,000
+16.8%
877,718
+23.3%
0.00%
+50.0%
Q4 2017$8,369,000
+14.8%
711,707
+18.7%
0.00%0.0%
Q3 2017$7,289,000
+476.7%
599,366
+464.0%
0.00%
Q2 2017$1,264,000
+8.4%
106,272
+8.3%
0.00%
Q1 2017$1,166,000
+1.5%
98,123
-0.4%
0.00%
Q4 2016$1,149,000
-31.5%
98,495
-30.4%
0.00%
-100.0%
Q3 2016$1,677,000
+46.1%
141,433
+35.0%
0.00%
Q2 2016$1,148,000
+42.4%
104,779
+37.9%
0.00%
Q1 2016$806,000
+41.9%
75,960
+35.0%
0.00%
Q4 2015$568,000
+11.8%
56,258
+12.9%
0.00%
Q3 2015$508,000
+96.9%
49,849
+128.2%
0.00%
Q2 2015$258,000
-51.7%
21,849
-49.5%
0.00%
Q1 2015$534,000
+86.7%
43,250
+86.0%
0.00%
Q4 2014$286,000
-8.6%
23,247
-4.1%
0.00%
Q3 2014$313,000
-48.0%
24,252
-44.1%
0.00%
Q2 2014$602,000
+75.0%
43,418
+72.1%
0.00%
Q1 2014$344,000
+15.8%
25,230
+12.5%
0.00%
Q4 2013$297,000
-6.9%
22,435
-8.2%
0.00%
Q3 2013$319,000
-27.0%
24,437
-28.4%
0.00%
Q2 2013$437,00034,1140.00%
Other shareholders
NEUBERGER BERMAN HGH YLD FD shareholders Q2 2016
NameSharesValueWeighting ↓
Shaker Financial Services, LLC 264,998$2,867,0001.41%
Vivaldi Capital Management LP 102,582$1,110,0000.91%
ROBINSON CAPITAL MANAGEMENT, LLC 289,112$3,128,0000.91%
Uncommon Cents Investing LLC 76,965$833,0000.54%
RIVERNORTH CAPITAL MANAGEMENT, LLC 559,900$6,058,0000.48%
Saba Capital Management, L.P. 571,468$6,183,0000.38%
DOLIVER ADVISORS, LP 59,204$641,0000.27%
SHEPHERD KAPLAN KROCHUK, LLC 33,180$359,0000.22%
Wunderlich Capital Managemnt 24,993$270,0000.19%
AEGON USA Investment Management, LLC 53,450$595,0000.17%
View complete list of NEUBERGER BERMAN HGH YLD FD shareholders